PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
86 hedge funds and large institutions have $108M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Holders
86
Holding in Top 10
1
Calls
$235K
Puts
$39K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.48M | |
| 3 | +$579K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$531K |
| 5 |
Goldman Sachs
New York
|
+$518K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$762K | |
| 3 | -$748K | |
| 4 |
Morgan Stanley
New York
|
-$659K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$617K |